Literature DB >> 29309901

Ischemia/reperfusion-associated tubular cells injury in renal transplantation: Can metabolomics inform about mechanisms and help identify new therapeutic targets?

Chantal Barin-Le Guellec1, Bérenger Largeau2, Delphine Bon3, Pierre Marquet4, Thierry Hauet3.   

Abstract

Tubular cells are central targets of ischemia-reperfusion (I/R) injury in kidney transplantation. Inflammation and metabolic disturbances occurring within these cells are deleterious by themselves but also favor secondary events, such as activation of immune response. It is critical to have an in depth understanding of the mechanisms governing tubular cells response to I/R if one wants to define pertinent biomarkers or to elaborate targeted therapeutic interventions. As oxidative damage was shown to be central in the patho-physiological mechanisms, the impact of I/R on proximal tubular cells metabolism has been widely studied, contrary to its effects on expression and activity of membrane transporters of the proximal tubular cells. Yet, temporal modulation of transporters over ischemia and reperfusion periods appears to play a central role, not only in the induction of cells injury but also in graft function recovery. Metabolomics in cell models or diverse biofluids has the potential to provide large pictures of biochemical consequences of I/R. Metabolomic studies conducted in experimental models of I/R or in transplanted patients indeed retrieved metabolites belonging to the pathways known to be particularly affected. Interestingly, they also revealed that metabolic disturbances and transporters activities are in very close mutual interplay. As well as helping to select diagnostic biomarkers, such analyses could also contribute to identify new pharmacological targets and to set up innovative nephroprotective strategies for the future. Even if various therapeutic approaches have been evaluated for a long time to prevent or treat I/R injuries, metabolomics has helped identifying new ones, those related to membrane transporters seeming to be of particular interest. However, considering the very complex and multifactorial effects of I/R in the context of kidney transplantation, all tracks must be followed if one wants to prevent or limit its deleterious consequences.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ischemia-reperfusion; Kidney transplantation; Membrane transport proteins; Metabolomics; Nephroprotectants

Mesh:

Year:  2018        PMID: 29309901     DOI: 10.1016/j.phrs.2017.12.032

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  4 in total

Review 1.  Therapeutic Potential of Annexin A1 in Ischemia Reperfusion Injury.

Authors:  Junaid Ansari; Gaganpreet Kaur; Felicity N E Gavins
Journal:  Int J Mol Sci       Date:  2018-04-16       Impact factor: 5.923

2.  Long non-coding RNA TUG1 knockdown promotes autophagy and improves acute renal injury in ischemia-reperfusion-treated rats by binding to microRNA-29 to silence PTEN.

Authors:  Zhiquan Xu; Xiaoyan Huang; Qiuyu Lin; Wei Xiang
Journal:  BMC Nephrol       Date:  2021-08-24       Impact factor: 2.388

3.  Inhibition of PLK3 Attenuates Tubular Epithelial Cell Apoptosis after Renal Ischemia-Reperfusion Injury by Blocking the ATM/P53-Mediated DNA Damage Response.

Authors:  Weiming Deng; Xiangling Wei; Zhenwei Xie; Rui Zhang; Zhanwen Dong; Jinhua Zhang; You Luo; Qingdi Cheng; Ruojiao Wang; Heng Li; Ning Na
Journal:  Oxid Med Cell Longev       Date:  2022-06-24       Impact factor: 7.310

4.  Proteo-metabolomics reveals compensation between ischemic and non-injured contralateral kidneys after reperfusion.

Authors:  Honglei Huang; Leon F A van Dullemen; Mohammed Z Akhtar; Maria-Letizia Lo Faro; Zhanru Yu; Alessandro Valli; Anthony Dona; Marie-Laëtitia Thézénas; Philip D Charles; Roman Fischer; Maria Kaisar; Henri G D Leuvenink; Rutger J Ploeg; Benedikt M Kessler
Journal:  Sci Rep       Date:  2018-06-04       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.